BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abdelgawad M, Bakry NS, Farghali AA, Abdel-Latif A, Lotfy A. Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects. Stem Cell Res Ther 2021;12:469. [PMID: 34419143 DOI: 10.1186/s13287-021-02542-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Udugma IA, Badr S, Hirono K, Scholz BX, Hayashi Y, Kino-oka M, Sugiyama H. The Role of Process Systems Engineering in Applying Quality by Design (QbD) in Mesenchymal Stem Cell Production. Computers & Chemical Engineering 2023. [DOI: 10.1016/j.compchemeng.2023.108144] [Reference Citation Analysis]
2 Motallebnezhad M, Omraninava M, Esmaeili Gouvarchin Ghaleh H, Jonaidi-Jafari N, Hazrati A, Malekpour K, Bagheri Y, Izadi M, Ahmadi M. Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19. Pathol Res Pract 2023;241:154280. [PMID: 36580795 DOI: 10.1016/j.prp.2022.154280] [Reference Citation Analysis]
3 Wu Q, Fu S, Xiao H, Du J, Cheng F, Wan S, Zhu H, Li D, Peng F, Ding X, Wang L. Advances in Extracellular Vesicle Nanotechnology for Precision Theranostics. Adv Sci (Weinh) 2023;10:e2204814. [PMID: 36373730 DOI: 10.1002/advs.202204814] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jahangiri B, Saei AK, Obi PO, Asghari N, Lorzadeh S, Hekmatirad S, Rahmati M, Velayatipour F, Asghari MH, Saleem A, Moosavi MA. Exosomes, autophagy and ER stress pathways in human diseases: Cross-regulation and therapeutic approaches. Biochim Biophys Acta Mol Basis Dis 2022;1868:166484. [PMID: 35811032 DOI: 10.1016/j.bbadis.2022.166484] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bi Y, Qiao X, Liu Q, Song S, Zhu K, Qiu X, Zhang X, Jia C, Wang H, Yang Z, Zhang Y, Ji G. Systemic proteomics and miRNA profile analysis of exosomes derived from human pluripotent stem cells. Stem Cell Res Ther 2022;13:449. [PMID: 36064647 DOI: 10.1186/s13287-022-03142-1] [Reference Citation Analysis]
6 Kirkham AM, Bailey AJM, Monaghan M, Shorr R, Lalu MM, Fergusson DA, Allan DS. Updated Living Systematic Review and Meta-analysis of Controlled Trials of Mesenchymal Stromal Cells to Treat COVID-19: A Framework for Accelerated Synthesis of Trial Evidence for Rapid Approval-FASTER Approval. Stem Cells Transl Med 2022:szac038. [PMID: 35758400 DOI: 10.1093/stcltm/szac038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Zoulikha M, Huang F, Wu Z, He W. COVID-19 inflammation and implications in drug delivery. J Control Release 2022;346:260-74. [PMID: 35469984 DOI: 10.1016/j.jconrel.2022.04.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Hirono K, A. Udugama I, Hayashi Y, Kino-oka M, Sugiyama H. A Dynamic and Probabilistic Design Space Determination Method for Mesenchymal Stem Cell Cultivation Processes. Ind Eng Chem Res 2022;61:7009-7019. [DOI: 10.1021/acs.iecr.2c00374] [Reference Citation Analysis]
9 Krishnan A, Muthusamy S, Fernandez FB, Kasoju N. Mesenchymal Stem Cell-Derived Extracellular Vesicles in the Management of COVID19-Associated Lung Injury: A Review on Publications, Clinical Trials and Patent Landscape. Tissue Eng Regen Med 2022. [PMID: 35384633 DOI: 10.1007/s13770-022-00441-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Watt SM, Smw. The long and winding road: homeostatic and disordered haematopoietic microenvironmental niches: a narrative review. Biomater Transl 2022;3:31-54. [PMID: 35837343 DOI: 10.12336/biomatertransl.2022.01.005] [Reference Citation Analysis]
11 Phua VJX, Yang C, Xia B, Yan SX, Liu J, Aw SE, He T, Ng DCE. Nanomaterial Probes for Nuclear Imaging. Nanomaterials 2022;12:582. [DOI: 10.3390/nano12040582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ghaffari S, Kazerooni H, Salehi-Najafabadi A. An overview of the recent findings of cell-based therapies for the treatment and management of COVID-19. Int Immunopharmacol 2021;101:108226. [PMID: 34634685 DOI: 10.1016/j.intimp.2021.108226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Bakry NS, Abdelgawad M, Abdel-Latif A, Lotfy A. Mesenchymal stromal cells coated with anti-ACE2 antibodies might improve efficacy against COVID-19. Hum Cell 2021. [PMID: 34591281 DOI: 10.1007/s13577-021-00620-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]